id: compromised_immune_system_cancer_to_lung_inflammation_susceptibility
name: Compromised Immune System in Cancer Patients â†’ Susceptibility to Lung Inflammation
  and Infections
from_node:
  node_id: compromised_immune_system_cancer
  node_name: Compromised Immune System in Cancer Patients
to_node:
  node_id: lung_inflammation_susceptibility
  node_name: Susceptibility to Lung Inflammation and Infections
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Cancer and its treatments compromise the immune system function'
- 'Step 2: Immunocompromised state reduces ability to fight pathogens and control
  inflammatory responses'
- 'Step 3: Reduced immune surveillance and dysregulated immune responses increase
  vulnerability to lung infections and inflammation'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Cong Li et al. 2024. "Conquering dual challenges: A sialic acid-modified
    liposome for targeting activated neutrophils to tackle comorbid lung inflammation
    and cancer metastasis.." *Journal of controlled release : official journal of
    the Controlled Release Society*. https://doi.org/10.1016/j.jconrel.2024.10.048'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.119039'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
